TradingViewTradingView

CNO Financial Group 3Q 2026: Revenue $1.09B, EPS $1.71 — 10-Q Summary

Okuma süresi: 1 dakikadan kısa

CNO Financial Group’s revenue declined year over year, while net income rose. Higher insurance product margins and investment income not allocated to product lines supported earnings; lower investment results weighed on revenue, while the absence of the prior-year impairment charge also aided the comparison.

Financial Highlights

MetricCurrent quarterPrior year quarterYoY change
Revenue¹$1.09B$1.19B(8.6%)
Net income²$161.1M$23.1M597.4%
Diluted EPS³$1.71$0.24612.5%

¹ Reported as “Total revenues”. ² Reported as “Net income”. ³ Reported as “Net income”.

Business Highlights

  • Insurance margins: Total insurance product margin increased to $333.0 million from $300.5 million; annuity and life margins rose, while health margin declined.
  • Investment income: Investment income not allocated to product lines rose to $68.1 million from $39.5 million, reflecting higher alternative investment results and increased FHLB and FABN spread income.
  • Actuarial review: The annual review had a net favorable $56.3 million impact on pre-tax operating earnings and a net favorable $36.0 million impact on net income.
  • 2026 outlook: Full-year operating earnings per diluted share guidance rose to $5.05-$5.15; expected expense ratio narrowed to 18.6%-18.8%.

Original SEC Filing: CNO Financial Group, Inc. [ CNO ] - 10-Q - Nov. 05, 2026

Feragatname